Baseline Variables | VAT N = 34 | No VAT N = 200 | p value |
Age (years) | 62.1 ± 13.6 | 65.7 ± 13.6 | 0.16 |
Male | 73.5% | 60.5% | 0.15 |
Body Mass Index | 33.0 ± 13.0 | 29.9 ± 9.4 | 0.12 |
Charlson Comorbidity | 1.7 ± 1.9 | 2.3 ± 2.1 | 0.10 |
APACHE IIa | 18.1 ± 6.9 | 17.6 ± 5.7 | 0.74 |
CPISb at Study Entry | 5 (2 - 8) | 4 (1 - 8) | 0.0001 |
Average CPISc | 5 (4 - 8) | 4 (1 - 8) | <0.0001 |
CPISd at Diagnosis Day | 6 (4 - 10) | - | - |
Antibiotics at Study Entry | 73.5% | 89.5% | 0.01 |
MICUe (N = 153) SICUf (N = 81) | 13.1% (20) 17.3% (14) | 86.9% (133) 82.7% (67) | 0.38 |